Glycuronamides, glycosides and orthoester glycosides of...

Details Glycuronamides, glycosides and orthoester glycosides of... Glycuronamides, glycosides and orthoester glycosides of...

2007-05-15

2007-05-15

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S025000, C514S646000, C536S001110, C536S018700, C536S115000

Reexamination Certificate

active

10506012

ABSTRACT:
Disclosed are glycosides, orthoester glycosides and glycuronamides of fluoxetine and analogs thereof to treat conditions and diseases such as depression.

REFERENCES:
patent: 4261974 (1981-04-01), Buckler et al.
patent: 4292425 (1981-09-01), Buckler et al.
patent: 4595695 (1986-06-01), Ladkani et al.
patent: 4599418 (1986-07-01), Irikura et al.
patent: 4751219 (1988-06-01), Kempen
patent: 4774230 (1988-09-01), Tuttle et al.
patent: 4855463 (1989-08-01), Barua et al.
patent: 4894476 (1990-01-01), Butler et al.
patent: 4897382 (1990-01-01), della Valle et al.
patent: 4939174 (1990-07-01), Shashoua
patent: 5051448 (1991-09-01), Shashoua
patent: 5114976 (1992-05-01), Norden
patent: 5162573 (1992-11-01), Chiesi et al.
patent: 5179093 (1993-01-01), Afonso et al.
patent: 5340803 (1994-08-01), Rubin
patent: 5412083 (1995-05-01), Giese et al.
patent: 5432260 (1995-07-01), Stahl
patent: 5436253 (1995-07-01), Rinaldi et al.
patent: 5436325 (1995-07-01), Johnson et al.
patent: 5440023 (1995-08-01), Cheng et al.
patent: 5466681 (1995-11-01), Krivan et al.
patent: 5506224 (1996-04-01), della Valle et al.
patent: 5508392 (1996-04-01), Holick
patent: 5518738 (1996-05-01), Eickhoff et al.
patent: 5559235 (1996-09-01), Luzzio et al.
patent: 5561119 (1996-10-01), Jacquesy et al.
patent: 5599953 (1997-02-01), Curley, Jr. et al.
patent: 5633357 (1997-05-01), Tius et al.
patent: 5677286 (1997-10-01), Shull et al.
patent: 5679667 (1997-10-01), Della Valle et al.
patent: 5707605 (1998-01-01), Meade et al.
patent: 5707663 (1998-01-01), Ayer et al.
patent: 5760072 (1998-06-01), de Bont et al.
patent: 5808111 (1998-09-01), Curley, Jr.
patent: 5827819 (1998-10-01), Yatvin et al.
patent: 5977326 (1999-11-01), Scheinmann et al.
patent: 5994392 (1999-11-01), Shashoua
patent: 6024977 (2000-02-01), Yatvin et al.
patent: 6043367 (2000-03-01), Roffler et al.
patent: 6074625 (2000-06-01), Hawthorne et al.
patent: 6107499 (2000-08-01), Shashoua
patent: 6166089 (2000-12-01), Kozak
patent: 6167313 (2000-12-01), Gray et al.
patent: 6207700 (2001-03-01), Kalgutkar et al.
patent: 6214345 (2001-04-01), Firestone et al.
patent: 6218519 (2001-04-01), Kenten et al.
patent: 6277818 (2001-08-01), Mazar et al.
patent: 6287598 (2001-09-01), Ayer et al.
patent: 6313106 (2001-11-01), Kozak
patent: 6316027 (2001-11-01), Johnson et al.
patent: 6339060 (2002-01-01), Yatvin et al.
patent: 6548484 (2003-04-01), Christian
patent: 7001888 (2006-02-01), Tidmarsh et al.
patent: 2001/0041676 (2001-11-01), Holick et al.
patent: 2002/0002140 (2002-01-01), Holick et al.
patent: 2003/0216328 (2003-11-01), Holick et al.
patent: 2004/0087559 (2004-05-01), Schwartz et al.
patent: 2005/0107310 (2005-05-01), Holick et al.
patent: 2005/0153928 (2005-07-01), Holick et al.
patent: 2005/0215487 (2005-09-01), Holick et al.
patent: 2005/0233949 (2005-10-01), Holick et al.
patent: 2005/0255038 (2005-11-01), Holick et al.
patent: 1029222 (1966-05-01), None
patent: WO 92/18005 (1992-10-01), None
patent: WO 94/14411 (1994-07-01), None
patent: WO 96/03995 (1996-02-01), None
Lemberger et al. (Journal of Clinical Psychiatry (1985), vol. 46:3 (Sec. 2), pp. 14-19.
Ali, S.A. et al., “Improving the Tumor Retention of Radioiodinated Antibody: Aryl Carbohydrate Adducts,”Canc. Res. (Suppl.) 50:783S-788S, American Association for Cancer Research (1990).
Database STN Easy, Accession No. 2001:136552, Haubner et al. (Feb. 2001).
Murakami, K. et al., “Excretion of New Quinolones and their Glucuronide Conjugates into Human Bile,”Drugs 49(Suppl. 2):331-332, Adis International Limited (1995).
Strobel, J.L. et al., “125I-Glycoconjugate Labels for Identifying Sites of Protein Catabolismin Vivo: Effect of Structure and Chemistry of Coupling to Protein on Label Entrapment in Cells after Protein Degradation,”Arch. Biochem. And Biophys. 240:635-645, Academic Press, Inc. (1985).
Esmond, R.W., Applicants' Amendents to the Claims for U.S. Appl. No. 10/512,848, 3 pages, “Amendment and Reply Under 37 C.F.R. § 1.111” (filed Mar. 2, 2006).
Fernández, C. et al., “Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents,”Carbohydrate Research 327:353-365, Elsevier Science Ltd. (2000).
Maryanoff, B.E. et al, “Anticonvulsant O-Alkyl Sulfamates. 2,3,4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose Sulfamate and Related Compounds,”J. Med. Chem. 30:880-887, American Chemical Society (1987).
Maryanoff, B.E. et al., “Structure-Activity Studies on Anticonvulsant Sugar Sulfamates Related to Topiramate. Enhanced Potency with Cyclic Sulfate Derivatives,”J. Med. Chem. 41:1315-1343, American Chemical Society (1998).
Remington's Pharmaceutical Sciences, Osol, A., et al., eds., 16thedition, Chapter 36, pp. 677-678, Philadelphia College of Pharmacy and Science (1980).
Rowley, M. et al., “Effect of Plasma Protein Binding on in Vivo Activity and Brain Penetration of Glycine/NMDA Receptor Antagonists,”J. Med. Chem. 40:4053-4068, American Chemical Society (1997).
Office Action for U.S. Appl. No. 10/512,848, Holick, M.F., et al., filed Oct. 29, 2004, mailed Dec. 15, 2005.

Affiliated with

Also associated with

Rating

Glycuronamides, glycosides and orthoester glycosides of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycuronamides, glycosides and orthoester glycosides of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycuronamides, glycosides and orthoester glycosides of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3807916